AVEO PHARMACEUTICALS, INC. Quarterly Debt-to-equity in % from Q1 2017 to Q3 2022

Taxonomy & unit
ratio: %
Description
Debt-to-equity (D/E) ratio is used to evaluate a company's financial leverage and is calculated by dividing a company's total liabilities by its shareholder equity.
Summary
Aveo Pharmaceuticals, Inc. quarterly Debt-to-equity history and growth rate from Q1 2017 to Q3 2022.
  • Aveo Pharmaceuticals, Inc. Debt-to-equity for the quarter ending September 30, 2022 was 183 %, a 104% increase year-over-year.
Debt-to-equity, Quarterly (%)
Debt-to-equity, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date
Q3 2022 183 +93.3 +104% Sep 30, 2022
Q2 2022 150 +66.8 +80.8% Jun 30, 2022
Q1 2022 119 +44.2 +59% Mar 31, 2022
Q4 2021 97.9 +3.31 +3.5% Dec 31, 2021
Q3 2021 89.9 -26 -22.4% Sep 30, 2021
Q2 2021 82.7 -70.6 -46.1% Jun 30, 2021
Q1 2021 74.9 -276 -78.7% Mar 31, 2021
Q4 2020 94.6 -876 -90.3% Dec 31, 2020
Q3 2020 116 +830 Sep 30, 2020
Q2 2020 153 +366 Jun 30, 2020
Q1 2020 351 +514 Mar 31, 2020
Q4 2019 971 +1.13K Dec 31, 2019
Q3 2019 -714 -545 -323% Sep 30, 2019
Q2 2019 -212 -26.5 -14.3% Jun 30, 2019
Q1 2019 -163 +51.7 +24% Mar 31, 2019
Q4 2018 -162 +110 +40.4% Dec 31, 2018
Q3 2018 -169 +174 +50.8% Sep 30, 2018
Q2 2018 -186 +1.02K +84.6% Jun 30, 2018
Q1 2018 -215 -1.07K -125% Mar 31, 2018
Q4 2017 -271 Dec 31, 2017
Q3 2017 -343 Sep 30, 2017
Q2 2017 -1.2K Jun 30, 2017
Q1 2017 856 Mar 31, 2017
* An asterisk sign (*) next to the value indicates that the value is likely invalid.